EUVIMEDEUVIMED entdecken
Crossref

CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves

Shreyas Kalantri, Brandon Smaglo

Annals of Pancreatic Cancer · 2026-05 · 9 · 13-13

DOI: 10.21037/apc-26-0011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-05. Verfasst von Shreyas Kalantri und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kalantri, S., & Smaglo, B. (2026). CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves. Annals of Pancreatic Cancer, 9, 13-13. https://doi.org/10.21037/apc-26-0011

Vancouver

Kalantri S, Smaglo B. CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves. Annals of Pancreatic Cancer. 2026;9:13-13. doi:10.21037/apc-26-0011

BibTeX
@article{Kalantri2026,
  author = {Kalantri, Shreyas and Smaglo, Brandon},
  title = {CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves},
  journal = {Annals of Pancreatic Cancer},
  year = {2026},
  volume = {9},
  pages = {13--13},
  doi = {10.21037/apc-26-0011}
}
Kostenlos starten →